Kubota Pharmaceutical Holdings CO Ltd (KBBTF) financial statements (2021 and earlier)

Company profile

Business Address 4-20-3 EBISU
TOKYO, 150-0013
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments122112104
Cash and cash equivalents9519
Short-term investments11310785
Receivables265
Deferred tax assets  0
Other undisclosed current assets323
Total current assets:127120112
Noncurrent Assets
Property, plant and equipment111
Long-term investments and receivables195584
Long-term investments195584
Other noncurrent assets000
Deferred tax assets, net  0
Total noncurrent assets:205685
TOTAL ASSETS:147176197
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities466
Accounts payable000
Accrued liabilities234
Employee-related liabilities222
Deferred revenue and credits036
Total current liabilities:5813
Noncurrent Liabilities
Liabilities, other than long-term debt110
Deferred revenue and credits110
Total noncurrent liabilities:110
Total liabilities:61013
Stockholders' equity
Stockholders' equity attributable to parent142166184
Common stock207192187
Additional paid in capital 64
Accumulated other comprehensive loss(0)(1)(0)
Accumulated deficit(66)(31)(5)
Total stockholders' equity:142166184
TOTAL LIABILITIES AND EQUITY:147176197

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
Gross profit:82435
Operating expenses(44)(51)(36)
Operating loss:(36)(27)(0)
Nonoperating income111
Investment income, nonoperating111
Interest and debt expense  (0)
Other undisclosed income from continuing operations before equity method investments, income taxes  0
Income (loss) from continuing operations before income taxes:(35)(25)0
Income tax expense(0)(0)(2)
Net loss available to common stockholders, diluted:(35)(26)(2)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
Net loss:(35)(26)(2)
Comprehensive loss:(35)(26)(2)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)
Comprehensive loss, net of tax, attributable to parent:(34)(26)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: